Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 6, 2009, Pages 1103-1110

  Yuan, Jianhui ^a   Lv, Hui ^a   Peng, Bo ^a   Wang, Chengkun ^a   Yu, Yanhui ^a   He, Zhimin ^a  

^a Central South University   (China)

Author keywords

5 Fluorouracil; BCRP; Multidrug resistance; RNAi

Indexed keywords

BIOLOGICAL MARKER; BREAST CANCER RESISTANCE PROTEIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; PACLITAXEL; PIRARUBICIN; VINCRISTINE; VINDESINE;

APOPTOSIS; ARTICLE; ASSAY; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA DAMAGE; DRUG RESISTANCE; DRUG RETENTION; FEMALE; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; RNA INTERFERENCE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CELL LINE, TUMOR; COMET ASSAY; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 63949083714     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0838-z     Document Type: Article

References (27)

1. LA Doyle W Yang LV Abruzzo T Krogmann Y Gao AK Rishi DD Ross 1998 A multidrug resistance transporter from human MCF-7 breast cancer cells Proc Natl Acad Sci USA 95 26 15665 15670
2. Schaub V, Hoffmann U, Blohmer JU, Grottke C, Mantwill K, Wichert A, Dietel M, Lage H (1997) Quantitative expression analysis of genes involved in development of chemoresistance in ovarian carcinoma in vitro and in vivo. 4th international symposium on cytostatic drug resistance, Berlin. Band of Abstracts, 96
3. DD Ross JE Karp TT Chen LA Doyle 2000 Expression of breast cancer resistance protein in blast cells from patients with acute leukemia Blood 96 1 365 368
4. Y Bessho T Oguri H Achiwa H Muramatsu H Maeda T Niimi S Sato R Ueda 2006 Role of ABCG2 as a biomarker for predicting resistance to CPT-11/SN-38 in lung cancer Cancer Sci 97 3 192 198
5. A Kanzaki M Toi K Nakayama H Bando M Mutoh T Uchida M Fukumoto Y Takebayashi 2001 Expression of multidrug resistance-related transporters in human breast carcinoma Jpn J Cancer Res 92 4 452 458
6. T Litman M Brangi E Hudson P Fetsch A Abati DD Ross K Miyake JH Resau SE Bates 2000 The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2) J Cell Sci 113 Pt 11 2011 2021
7. M Maliepaard MA van Gastelen LA de Jong D Pluim RC van Waardenburg MC Ruevekamp-Helmers BG Floot JH Schellens 1999 Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line Cancer Res 59 18 4559 4563
8. T Nakanishi JE Karp M Tan LA Doyle T Peters W Yang D Wei DD Ross 2003 Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patients Clin Cancer Res 9 3320 3328
9. H Lv Z He X Liu J Yuan Y Yu Z Chen 2007 Reversal of BCRP-mediated multidrug resistance by stable expression of small interfering RNAs J Cell Biochem 102 1 75 81
10. JH Yuan ZM He YH Yu ZC Chen 2004 Expression establishment and functional analysis of breast cancer resistance protein with doxycycline induced tet regulating system in mouse fibroblast cell line PA317 Ai Zheng 23 10 1127 1133
11. WJ Loos P de Bruijn J Verweij A Sparreboom 2000 Determination of camptothecin analogs in biological matrices by high-performance liquid chromatography Anticancer Drugs 11 5 315 324
12. F Kugawa A Ueno M Aoki 2000 Apoptosis of NG108-15 cells induced by buprenorphine hydrochloride occurs via the caspase-3 pathway Biol Pharm Bull 23 8 930 935
13. NP Singh MT McCoy RR Tice EL Schneider 1988 A simple technique for quantitation of low levels of DNA damage in individual cells Exp Cell Res 175 1 184 191
14. CJ Chen JE Chin K Ueda DP Clark I Pastan MM Gottesman IB Roninson 1986 Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell 47 3 381 389
15. SP Cole G Bhardwaj JH Gerlach JE Mackie CE Grant KC Almquist AJ Stewart EU Kurz AM Duncan RG Deeley 1992 Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 258 5088 1650 1654
16. P Borst R Evers M Kool J Wijnholds 2000 A family of drug transporters: the multidrug resistance-associated proteins J Natl Cancer Inst 92 16 1295 1302
17. K Miyake L Mickley T Litman Z Zhan R Robey B Cristensen M Brangi L Greenberger M Dean T Fojo SE Bates 1999 Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes Cancer Res 59 1 8 13
18. F Kugawa A Ueno M Kawasaki M Aoki 2004 Evaluation of cell death caused by CDF (cyclophosphamide, doxorubicin, 5-fluorouracil) multi-drug administration in the human breast cancer cell line MCF-7 Biol Pharm Bull 27 3 392 398
19. JA Oshaughnessy J Blum V Moiseyenko SE Jones D Miles D Bell R Rosso L Mauriac B Osterwalder HU Burger S Laws 2001 Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer Ann Oncol 12 9 1247 1254
20. Rosa DD, Awada A, Cardoso F, Gil T, Lebrun F, Mano MS, Selleslags J, Piccart MJ, D'Hondt V (2007) Oxaliplatin and 5-fluorouracil in heavily pretreated patients with ovarian carcinoma: a well tolerated and efficient treatment. ASCO Meeting Abstracts, vol 25. p 16028
21. M Okamura M Kobayashi F Suzuki J Shimada H Sakagami 2007 Induction of cell death by combination treatment with cisplatin and 5-fluorouracil in a human oral squamous cell carcinoma cell line Anticancer Res 27 5A 3331 3337
22. Z He J Yuan Z Chen S Liu Z Shen H Fei 1998 Chemosensitivity test for 170 human breast carcinoma samples Hunan Yi Ke Da Xue Xue Bao 23 6 531 534
23. M Maliepaard GL Scheffer IF Faneyte MA van Gastelen AC Pijnenborg AH Schinkel MJ van De Vijver RJ Scheper JH Schellens 2001 Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues Cancer Res 61 8 3458 3464
24. JW Jonker JW Smit RF Brinkhuis M Maliepaard JH Beijnen JH Schellens AH Schinkel 2000 Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan J Natl Cancer Inst 92 20 1651 1656
25. CM Kruijtzer JH Beijnen H Rosing WW ten Bokkel Huinink M Schot RC Jewell EM Paul JH Schellens 2002 Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918 J Clin Oncol 20 13 2943 2950
26. U Hoffmann V Materna JU Blohmer 2000 Quantitative expression analysis of genes involved in the development of chemoresistance in ovarian carcinoma Pathol Res Pract 196 235 238
27. YS Mao D Austin DD Ross 2001 BCRP gene expression in normal lung and in non-small cell lung cancer tissue Chin J Cancer 20 274 278